Canopy Growth Corp Fair Value Adjustment of Warrants
Canopy Growth Corp (CGC) reported Fair Value Adjustment of Warrants of -CAD 26.92 million for the 12-month period ending 2023-03-31, per its 10-K filed 2025-05-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-05-30
- Canopy Growth Corp fair value adjustment of warrants for the quarter ending 2023-03-31 was -668.00K CAD.
- Canopy Growth Corp fair value adjustment of warrants for the quarter ending 2022-12-31 was -23.00K CAD.
- Canopy Growth Corp fair value adjustment of warrants for the quarter ending 2022-09-30 was -864.00K CAD.
- Canopy Growth Corp fair value adjustment of warrants for the quarter ending 2022-06-30 was -25.36M CAD.
- Canopy Growth Corp fair value adjustment of warrants for fiscal 2023 was -26.92M CAD.
- Canopy Growth Corp fair value adjustment of warrants for fiscal 2022 was -588.65M CAD, a 300.85% decline from fiscal 2021.
- Canopy Growth Corp fair value adjustment of warrants for fiscal 2021 was 293.08M CAD.
- Canopy Growth Corp fair value adjustment of warrants for fiscal 2020 was -795.15M CAD.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2023-03-31 | -668.00K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | -691.00K CAD derived: sum of 2 quarters · filed 2025-05-30 | -1.55M CAD derived: sum of 3 quarters · filed 2025-05-30 | -26.92M CAD 10-K · filed 2025-05-30 |
| 2022-12-31 | -23.00K CAD 10-Q · filed 2024-02-09 | -887.00K CAD derived: sum of 2 quarters · filed 2024-02-09 | -26.25M CAD 10-Q · filed 2024-02-09 | -36.82M CAD derived: sum of 4 quarters · filed 2024-05-30 |
| 2022-09-30 | -864.00K CAD 10-Q · filed 2023-11-09 | -26.23M CAD 10-Q · filed 2023-11-09 | -36.80M CAD derived: sum of 3 quarters · filed 2024-05-30 | -104.08M CAD derived: sum of 4 quarters · filed 2024-05-30 |
| 2022-06-30 | -25.36M CAD 10-Q · filed 2023-08-09 | -35.94M CAD derived: sum of 2 quarters · filed 2024-05-30 | -103.22M CAD derived: sum of 3 quarters · filed 2024-05-30 | -297.76M CAD derived: sum of 4 quarters · filed 2024-05-30 |
| 2022-03-31 | -10.57M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-30 | -77.85M CAD derived: sum of 2 quarters · filed 2024-05-30 | -272.40M CAD derived: sum of 3 quarters · filed 2024-05-30 | -588.65M CAD 10-K · filed 2024-05-30 |
| 2021-12-31 | -67.28M CAD 10-Q · filed 2023-02-09 | -261.83M CAD derived: sum of 2 quarters · filed 2023-02-09 | -578.08M CAD 10-Q · filed 2023-02-09 | -378.45M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-09-30 | -194.54M CAD 10-Q · filed 2022-11-09 | -510.80M CAD 10-Q · filed 2022-11-09 | -311.17M CAD derived: sum of 3 quarters · filed 2023-06-22 | -117.17M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-06-30 | -316.26M CAD 10-Q · filed 2022-08-09 | -116.63M CAD derived: sum of 2 quarters · filed 2023-06-22 | 77.37M CAD derived: sum of 3 quarters · filed 2023-06-22 | 12.20M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-03-31 | 199.63M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 393.63M CAD derived: sum of 2 quarters · filed 2023-06-22 | 328.45M CAD derived: sum of 3 quarters · filed 2023-06-22 | 293.08M CAD 10-K · filed 2023-06-22 |
| 2020-12-31 | 194.00M CAD 10-Q · filed 2022-02-09 | 128.82M CAD derived: sum of 2 quarters · filed 2022-02-09 | 93.45M CAD 10-Q · filed 2022-02-09 | 47.56M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-09-30 | -65.17M CAD 10-Q · filed 2021-11-08 | -100.54M CAD 10-Q · filed 2021-11-08 | -146.43M CAD derived: sum of 3 quarters · filed 2022-05-31 | -228.95M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-06-30 | -35.37M CAD 10-Q · filed 2021-08-06 | -81.26M CAD derived: sum of 2 quarters · filed 2022-05-31 | -163.77M CAD derived: sum of 3 quarters · filed 2022-05-31 | -805.63M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-03-31 | -45.89M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | -128.40M CAD derived: sum of 2 quarters · filed 2022-05-31 | -770.26M CAD derived: sum of 3 quarters · filed 2022-05-31 | -795.15M CAD 10-K · filed 2022-05-31 |
| 2019-12-31 | -82.51M CAD 10-Q · filed 2021-02-09 | -724.37M CAD derived: sum of 2 quarters · filed 2021-02-09 | -749.26M CAD 10-Q · filed 2021-02-09 | |
| 2019-09-30 | -641.85M CAD 10-Q · filed 2020-11-09 | -666.75M CAD 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -24.89M CAD 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |